- 询价
- MedChemExpress(MCE)
- 美国
- HY-101750
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存：
货期：询盘
- 供应商：
MedChemExpress LLC
- CAS号：
335619-12-0
- 规格：
询盘
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Arrhythmias-Targeting Compound 1
CAS No. : 335619-12-0
MCE 国际站：Arrhythmias-Targeting Compound 1
产品活性：Arrhythmias-Targeting Compound 1 可用于心律失常的研究，摘自专利 WO 2001028992 A2。
研究领域：Others
作用靶点：Others
In Vivo: Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, in particular atrial and ventricular arrhythmias.
相关产品：Digitonin | 5-Ph-IAA | FLAG peptide | Tocofersolan | Monocrotaline | Lactate sodium | TCEP hydrochloride | 3X FLAG peptide | DPPH | Pertussis Toxin | Pronase E (Activity ≥ 7000 U/g) | O-Propargyl-Puromycin | NMDI14 | Phytohemagglutinin | MYLS22 | Hyaluronidase | Biotinyl tyramide | Kifunensine | Human IgG1 kappa, Isotype Control | 4-Azido-L-phenylalanine | 6-Aminonicotinamide | Ammonium tetrathiomolybdate(VI) | OVA Peptide(257-264) TFA | Alkyne-phenol | Lauryl maltose neopentyl glycol | SHIN1 | CHAPS | Cytosporone B
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Targeting of Antibodies Using Aptamers
Antibodies are traditionally viewed as targeting entities that are used to specifically recognize and target other molecules, antigens, or receptors. However, there are occasions in which cognate ligands are generated against the antibodies
Gene Targeting of Retinoid Receptors
Gene targeting in embryonic stem (ES) cells is a powerful technique for the modification of the mouse genome (1 –3 ). Regarding the retinoid receptors, a number of laboratories have reported the phenotype of mice in which a given retinoic acid
Five-Step Process for Screening Antisense Compounds for Efficacy: Gene Target IL-12Rb2
compound for altering IL-12Rb2 expression including (1) detecting mRNA splice products by RT-PCR, (2) measuring protein expression, (3) evaluating protein function, (4) checking cellular viability, and (5) validating efficacy of the final candidate compound
技术资料暂无技术资料 索取技术资料
